Navigation Links
The Federal Trade Commission Files Lawsuit Seeking an Injunction Against Marketer of Weight-loss Products Over Alleged False Advertising, Parker Waichman LLP Reports
Date:11/1/2013

New York, New York (PRWEB) November 01, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of consumers, is informing the public that The Federal Trade Commission (FTC) has filed a lawsuit to obtain an injunction against the marketer of HCG Platinum weight-loss products, alleging the company uses false consumer advertising to convey the impression that its products are capable of bringing about the swift loss of substantial amounts of weight. The lawsuit was filed on Oct. 30, 2013, in U.S. District Court, District of Arizona (Case No. 2:13-cv-02215). Kevin Wright, HCG Platinum LLC and Right Way Nutrition LLC have been named defendants.

The weight-loss products marketed by the defendants contain HCG (human chorionic gonadotropin), a hormone in human placenta that “for decades has been falsely promoted by various marketers for weight loss,” according to the FTC’s Complaint. Products containing this hormone have already been in the spotlight as part of a combined effort between the FTC and the U.S. Food and Drug Administration (FDA), according to the Complaint, which further noted that in November 2011 the two agencies jointly sent warning letters to seven marketers of products that contained HCG – a group that included current defendant Kevin Wright. The warning letter revealed that the products offered by those marketers were actually mislabeled drugs in violation of sections of the Federal Food, Drug, and Cosmetic Act, and also illegal, based on the FTC Act, which renders illegal any weight loss claims not supported by reliable scientific evidence, according to the Complaint.

“The weight-loss business is rife with companies using unsupported marketing claims to promote what are usually lose-weight-quick products or schemes that don’t work,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “This is a consumer product category where the old adage ‘if it seems too good to be true, it probably is’ certainly fits.” Parker Waichman is currently evaluating cases for a pending class action lawsuit.

Marketing claims—featured on both packaging and in advertising—are a major concern, the Complaint said, noting that the marketers of the HCG Platinum line make various claims, including:

  •     Consumers will lose a pound or two per day for several weeks, for a total of up to 127 pounds;
  •     The products are safe and have been clinically proven to burn fat and reduce weight; and
  •     The products also can lower cholesterol.

If you or someone you know purchased an HCG Platinum brand product for personal use, you may have valuable legal rights. To find out more about joining an HCG Platinum class action lawsuit, please visit our website or contact one of our experienced class action lawyers today at 1(800)-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary P. Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/ftc_lawsuit_HCG/11/prweb11296522.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mirena Lawsuits Mount, as Bernstein Liebhard LLP Notes More than 400 Mirena IUD Lawsuit Filings in State, Federal Litigations
2. New report: Companies created from federally funded university research fuel american innovation, economic growth
3. Federal Biomet Hip Lawsuit Litigation Progresses with Recent Case List Update, Scheduling of Upcoming Case Management Conference, Bernstein Liebhard LLP Reports
4. Federal Biomet Hip Lawsuit Litigation Progresses with Recent Case List Update, Scheduling of Upcoming Case Management Conference, Bernstein Liebhard LLP Reports
5. Mirena IUD Lawsuit Help Update: Resource4thePeople Comments on New Developments in State and Federal Court Litigation
6. U.S. Federal Panel Vacates Order to Transfer Mirena Lawsuit to New York Litigation, Bernstein Liebhard LLP Reports
7. New Transvaginal Mesh Lawsuits Assistance: Resource4thePeople Reports Key Trials Scheduled by Federal Judge
8. Status Conference Scheduled for December in Federal Ethicon Transvaginal Mesh Lawsuit Litigation, More than 10,270 Gynecare Cases Now Filed in Proceeding
9. Over 2,500 Cases Now Filed in Federal Actos Lawsuit Litigation; Case Management Conference Scheduled to Take Place on Thursday
10. PCMA: Eight Ways to Reduce Federal Health Spending and Improve Prescription Drug Benefits in Medicare and Medicaid
11. Wright Hip Lawsuit News: Federal Judge Allows Certain Claims to Proceed in Wright Profemur Hip Replacement Lawsuit, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: